Jade Biosciences, Inc. (JBIO) Free cash flow 2021–2025
Jade Biosciences, Inc. (JBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$94.9MFY2025 · since FY2021: -$27.6M → -$94.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$94.9M | — |
| FY2023 | -$56.9M | -44.8% |
| FY2022 | -$39.3M | -42.6% |
| FY2021 | -$27.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More JBIO financial trends
JBIO RevenueJBIO Net incomeJBIO Net marginJBIO Gross profitJBIO Gross marginJBIO Operating incomeJBIO Operating marginJBIO Operating cash flowJBIO Capital expendituresJBIO Return on equityJBIO Stock buybacksJBIO Dividends paidJBIO Total assetsJBIO Total liabilitiesJBIO Shareholders’ equityJBIO overview →